InsidersTradesSigma
Browse the full record of transactions filed by Musket David B, Director. Director active across 1 companies, notably Capricor Therapeutics, INC.. Cumulatively, 4 disclosures have been published. Total volume traded: €176k. The latest transaction was disclosed on 29 June 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations
David B. Musket is a Director at Capricor Therapeutics, Inc. In this role, he participates in the governance of the company and strategic decision-making. Capricor Therapeutics, Inc. specializes in medical treatments. David B. Musket brings his expertise to help guide the company's direction.